Clinical Trial Details

Overview

Research Study Summary

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Purpose

The study will involve an eighteen-week, double-blind, placebo-controlled parallel designed comparison between add-on topiramate and add-on placebo to stable treatment with amatadine in the treatment of PD patients who continue to have dyskinesia on amantadine.

To Learn more

CW ID: 203066
Date Last Changed: November 6, 2014

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
30 to 90 Years
Overall Status
Recruiting
Lead Sponsor
MJFF
Facility Type
N/A

Contact

Claudia Rocha
University of South Florida - USF Health Byrd Alzheimer's Institute
4001 Fletcher Avenue
Tampa, FL 33613
Phone: (813)396-0757

View Map

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.